www.sciencedaily.com
A novel nasal nanotherapy targeting aggressive glioblastoma shows significant promise. Researchers utilized gold-core spherical nucleic acids to activate the STING immune pathway, delivering treatment directly to the brain without surgery. This method, combined with drugs enhancing T-cell activity, eradicated tumors in mice and established durable immunity. These findings highlight a potential breakthrough in brain cancer immunotherapy, offering a less invasive and highly effective approach to combatting this deadly disease. The study suggests a new avenue for developing therapies that stimulate the body’s own immune system to fight glioblastoma.
